Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling NF-κB transcription factors mediate the effects of pro-inflammatory cytokines such as tumour necrosis factor-α and interleukin-1β 1 . Failure to downregulate NF-κB transcriptional activity results in chronic inflammation and cell death, as observed in A20-deficient mice 2 . A20 is a potent inhibitor of NF-κB signalling, but its mechanism of action is unknown 2 . Here we show that A20 downregulates NF-κB signalling through the cooperative activity of its two ubiquitin-editing domains. The amino-terminal domain of A20, which is a de-ubiquitinating (DUB) enzyme of the OTU (ovarian tumour) family 3 , removes lysine-63 (K63)-linked ubiquitin chains from receptor interacting protein (RIP), an essential mediator of the proximal TNF receptor 1 (TNFR1) signalling complex 4,5 . The carboxy-terminal domain of A20, composed of seven C2/C2 zinc fingers 6 , then functions as a ubiquitin ligase by polyubiquitinating RIP with K48-linked ubiquitin chains, thereby targeting RIP for proteasomal degradation. Here we define a novel ubiquitin ligase domain and identify two sequential mechanisms by which A20 downregulates NF-κB signalling. We also provide an example of a protein containing separate ubiquitin ligase and DUB domains, both of which participate in mediating a distinct regulatory effect. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nature Springer Journals

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling

Download PDF
6 pages

Loading next page...
 
/lp/springer-journals/de-ubiquitination-and-ubiquitin-ligase-domains-of-a20-downregulate-nf-24RTah4zeG

References (38)

Publisher
Springer Journals
Copyright
Copyright © 2004 by Macmillan Magazines Ltd.
Subject
Science, Humanities and Social Sciences, multidisciplinary; Science, Humanities and Social Sciences, multidisciplinary; Science, multidisciplinary
ISSN
0028-0836
eISSN
1476-4687
DOI
10.1038/nature02794
Publisher site
See Article on Publisher Site

Abstract

NF-κB transcription factors mediate the effects of pro-inflammatory cytokines such as tumour necrosis factor-α and interleukin-1β 1 . Failure to downregulate NF-κB transcriptional activity results in chronic inflammation and cell death, as observed in A20-deficient mice 2 . A20 is a potent inhibitor of NF-κB signalling, but its mechanism of action is unknown 2 . Here we show that A20 downregulates NF-κB signalling through the cooperative activity of its two ubiquitin-editing domains. The amino-terminal domain of A20, which is a de-ubiquitinating (DUB) enzyme of the OTU (ovarian tumour) family 3 , removes lysine-63 (K63)-linked ubiquitin chains from receptor interacting protein (RIP), an essential mediator of the proximal TNF receptor 1 (TNFR1) signalling complex 4,5 . The carboxy-terminal domain of A20, composed of seven C2/C2 zinc fingers 6 , then functions as a ubiquitin ligase by polyubiquitinating RIP with K48-linked ubiquitin chains, thereby targeting RIP for proteasomal degradation. Here we define a novel ubiquitin ligase domain and identify two sequential mechanisms by which A20 downregulates NF-κB signalling. We also provide an example of a protein containing separate ubiquitin ligase and DUB domains, both of which participate in mediating a distinct regulatory effect.

Journal

Nature – Springer Journals

Published: Jul 18, 2004

There are no references for this article.